JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
View Older Stories View More Recent Stories
-
Confluent (CFLT) IPO Opens 22% Higher
-
AFC Gamma, Inc (AFCG) Prices 2.75M Share Offering at $20.50/sh
-
AFC Gamma, Inc. Prices Common Stock Offering
-
AFC Gamma, Inc. Prices Common Stock Offering
-
Confluent (CFLT) IPO Prices at $36
-
Confluent Announces Pricing of Initial Public Offering
-
Evelo Biosciences Inc (EVLO) PT Raised to $38 at JMP Securities, Following Clinical Business Update
-
Sprinklr (CXM) IPO Opens 9% Lower
-
Sprinklr (CXM) Prices 16.6M Share IPO at $16/sh
-
Sprinklr Announces Pricing of Initial Public Offering
-
SharpSpring (SHSP) to be Acquired by Clearlake Capital and Siris-Backed Constant Contact
-
Clearlake Capital and Siris-Backed Constant Contact Agrees to Acquire SharpSpring
-
Clearlake Capital and Siris-Backed Constant Contact Agrees to Acquire SharpSpring
-
Tremor International Ltd. Announces Closing of Offering
-
Legion Announces Appointment of Executive Hires
-
AFC Gamma (AFCG) to Offer 2.75M in Common Stock
-
AFC Gamma, Inc. Announces Launch of Common Stock Offering
-
AFC Gamma, Inc. Announces Launch of Common Stock Offering
-
Protagonist Therapeutics, Inc. Announces Closing of $132.2 Million Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Tremor International (TRMR) IPO Opens Flat
-
Ares Commercial Real Estate (ACRE) Prices 6.5M Shares of Common Stock for Gross Proceeds of Approximately $102.8 million
-
Ares Commercial Real Estate Corporation Announces Pricing of Offering of Common Stock
-
Tremor International (TRMR) IPO Prices at $19
-
Tremor International Ltd. Announces Pricing of Initial Public Offering
-
Ares Commercial Real Estate (ACRE) Announces Proposed Offering of 6.5M Shares
-
Ares Commercial Real Estate Corporation Announces Launch of Offering of Common Stock
-
Elevation Oncology Announces Appointment of Joseph Ferra as Chief Financial Officer
-
JMP Group Announces Partial Redemption of 7.25% Senior Notes Due 2027
-
Altimmune (ALT) PT Raised to $53 at JMP Securities
-
WalkMe Ltd. (WKME) IPO Opens Fractionally Higher
-
Digital Guardian Named to JMP Securities Elite 80 List of Hottest Privately Held Companies for Fifth Consecutive Year
-
Enterin to Present at JMP Securities Life Sciences Conference
-
WM Holding Company, LLC, a Leading Technology Platform to the Cannabis Industry, Completes Business Combination With Silver Spike Acquisition Corp.
-
WalkMe (WKME) IPO Prices at $31
-
Protagonist Therapeutics (PTGX) Announces Pricing of $115 Million Upsized Public Offering of Common Stock
-
WalkMe Announces Pricing of Initial Public Offering
-
Protagonist Therapeutics Announces Pricing of $115 Million Upsized Public Offering of Common Stock
-
Clearside Biomedical (CLSD) PT Raised to $9 at JMP Securities, Following Clinical Business Update
-
Sutro Biopharma to Participate in Two Virtual Investor Conferences in June
-
Arbor Realty Trust Announces Pricing of Public Offering of Common Stock
-
1stdibs.com, Inc. Announces Closing of Initial Public Offering
-
1stdibs.com, Inc. Announces Closing of Initial Public Offering
-
Protagonist Therapeutics (PTGX) Announces Proposed $100M Public Offering of Common Stock
-
Protagonist Therapeutics Announces Proposed Public Offering of Common Stock
-
Arbor Realty Trust (ABR) Announces 6M Share Public Offering of Common Stock
-
Arbor Realty Trust Announces Public Offering of Common Stock
-
Tremor International Ltd. Launches Initial Public Offering on Nasdaq
-
Cue Biopharma to Present at the Upcoming JMP Securities Life Sciences Conference
-
ReCode Therapeutics to Participate in Upcoming June Investor Conferences
-
eFFECTOR Therapeutics to Present at JMP Securities 2021 Life Sciences Conference

